丁磊:網易(09999.HK)具技術規劃發展元宇宙 會加大研發投入概念應用
網易(09999.HK)(NTES.US)創始人、首席執行官丁磊在業績後電話會議中迴應有關元宇宙問題時表示,網易已做好元宇宙的技術和規劃準備,等到時機成熟的一刻,網易有可能跑得比誰都快。未來將持續關注並加大研發投入,從概念走向應用爲社會創造價值。
丁磊提到,網易在線遊戲業務在多元化戰略方面成果頗豐,旗艦遊戲表現強勁。網易有道、網易雲音樂和網易嚴選繼續保持着多元化和差異化的產品佈局。
丁磊指出,在過去很長一段時間,內所地市場機制不夠完善,導致成爲世界上音樂版權最貴的國家和地區。國家市場監管總局月前已向競爭企業提出相關要求,相信該成本在國家的監管下會趨於合理。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.